Quality of life in patients with ovarian cancer: Current state of research (original) (raw)

References

  1. Aaronson NK, Beckmann JH (eds) (1987) The quality of life of cancer patients. Raven Press, New York
    Google Scholar
  2. Aaronson NK, Ahmedzai S, Bergman B, et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
    PubMed Google Scholar
  3. Anderson B (1994) Quality of life in progressive ovarian cancer. Gynaecol Oncol 55: S151-S155
    Google Scholar
  4. Austoker J (1994) Screening for ovarian, prostatic, and testicular cancers. Br Med J 309:315–320
    Google Scholar
  5. Black RJ, Sharp L, Kendrick SW (1993) Trends in cancer survival in Scotland: 1968–1990. Information and Statistics Division—NHS in Scotland, Edinburgh, p 44
    Google Scholar
  6. Bliss JM, Selby PJ, Robertson B, Powles TJ (1992) A method for assessing the quality of life of cancer patients: replication of the factor structure. Br J Cancer 65:961–966
    PubMed Google Scholar
  7. Blythe JG, Wahl TP (1982) Debulking surgery: does it increase the quality of survival? Gynaecol Oncol 14:396–408
    Google Scholar
  8. Bos-Branolte G, Zielstra EM, Rijshouwer YM, Duivenvoorden HJ (1988) Psychotherapy in patients cured of gynaecologic cancers. Recent Results Cancer Res 108:277–288
    PubMed Google Scholar
  9. Boyd NF, Selby PJ, Sutherland HJ, Hogg S (1988) Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales. J Clin Epidemiol 41:243–250
    PubMed Google Scholar
  10. Coates A, Dillenbeck CF, McNeil DR, et al (1983) On the receiving end. II. Linear analogue self-assessment (LASA) in evaluation of aspect of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 19:1633–1637
    PubMed Google Scholar
  11. Coates A, Abraham S, Kaye SB, et al (1983) On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203–208
    PubMed Google Scholar
  12. Crowther ME, Corney RH, Shepherd JH (1994) Psychosexual implications of gynaecological cancer. Talk about it. Br Med J 308:869–870
    Google Scholar
  13. Fallowfield LJ (1993) Quality of life measurement in breast cancer. J R Soc Med 86:10–12
    PubMed Google Scholar
  14. Fayers PM, Jones DR (1983) Measuring and analysing quality of life in cancer clinical trials: a review. Statist Med 2:429–446
    Google Scholar
  15. Furst CJ, Johansson S, Fredikson M, Hursti T, Steineck G, Peterson C (1992) Control of cisplatin induced emesis — a multidisplinary intervention strategy. Med Oncol Tumour Pharmacother 9:81–86
    Google Scholar
  16. Ganz PA (1994) Quality of life and the patient with cancer: individual and policy implications. Cancer 74:1445–1452
    PubMed Google Scholar
  17. Ganz PA, Haskell CM, Figlin RA, La Soto N, Siau J (1988) Estimating the quality of life in clinical trial of patients with metastatic lung cancer using the Karnofsky Performance Status and the Functional Living Index-Cancer. Cancer 61:849–856
    PubMed Google Scholar
  18. Gillis CR, Hole DJ, Still RM, Davis J, Kaye SB (1991) Medical audit, cancer registration, and survival in ovarian cancer. Lancet 337:611–612
    Google Scholar
  19. Gotay CC, Moore TD (1992) Assessing quality of life in head and neck cancer. Qual Life Res 1:5–17
    PubMed Google Scholar
  20. Granai CO (1992) Ovarian cancer — unrealistic expectations. N Engl J Med 373:194–200
    Google Scholar
  21. Guidozzi F (1993) Living with ovarian cancer. Gynaecol Oncol 50:202–207
    Google Scholar
  22. Haes JCJM de, Knippenberg FCE van (1985) The quality of life of cancer patients: a review of the literature. Soc Sci Med 20:809–817
    PubMed Google Scholar
  23. Haes JCJM de, Raatgever JW, Burg MEL ven der, Hamersma E, Neijt JP (1987) Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy. In: Aaronson NK, Beckman J (eds) The quality of life of cancer patients. Raven Press, New York, pp 215–226
    Google Scholar
  24. Haes JCJM de, Knippenberg FCE van, Nejit JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of Rotterdam Symptom Checklist. Br J Cancer 62:1034–1038
    PubMed Google Scholar
  25. Hays RD, Anderson R, Revicki D (1993) Psychometric consideration in evaluating health-related quality of life. Qual Life Res 2:441–449
    PubMed Google Scholar
  26. Hole D, Gillis CR (1993) Use of cancer registry data to evaluate the treatment of ovarian cancer on hospital basis. Health Rep 5:117–119
    PubMed Google Scholar
  27. Hopwood P, Stephens RJ, Machin D (1994) Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3:339–352
    PubMed Google Scholar
  28. Janicke F, Holscher M, Kuhn W, et al (1992) Radical surgical procedure improves survival time in patients with recurrence ovarian cancer. Cancer 70:2129–2136
    PubMed Google Scholar
  29. Jenkinson C (1994) Quality of life measurement: does it have a place in routine clinical assessment? J Psychsom Res 38:377–381
    Google Scholar
  30. Junor EJ, Hole DJ, Gillis CR (1994) Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 70:363–370
    PubMed Google Scholar
  31. King LA, Carson LF, Konstantinides N, et al (1993) Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? Gynaecol Oncol 51:377–382
    Google Scholar
  32. Levi F, Franceschi S, La Vecchia C, Ruzicka J, Gloor E, Randimbison L (1993) Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol 4:289–294
    PubMed Google Scholar
  33. Maguire P, Selby P (1989) Assessing quality of life in cancer patients. Br J Cancer 60:437–440
    PubMed Google Scholar
  34. Malone M, Harris AL, Luscombe DK (1994) Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J R Soc Med 87:386–389
    PubMed Google Scholar
  35. Markman M (1994) Follow-up of the asymptomatic patient with ovarian cancer. Gynaecol Oncol 55: S134-S137
    Google Scholar
  36. McDowell I, Newell C (1987) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York, p 213
    Google Scholar
  37. Mermelstein HT, Lesko L (1992) Depression in patients with cancer. Psycho-Oncology 1:199–215
    Google Scholar
  38. Montazeri A (1994) A study on quality of life in patients with ovarian cancer (research proposal). West of Scotland Health Services Research News 12:6
    Google Scholar
  39. Olschewski M, Schulgen G, Schumacher M, Altman DG (1994) Quality of life assessment in clinical cancer research. Br J Cancer 70:1–5
    PubMed Google Scholar
  40. Osoba D (ed) (1991) Effect of cancer on quality of life. CRC Press, Boca Raton, Fla
    Google Scholar
  41. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J (1994) Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 3:353–364
    PubMed Google Scholar
  42. Ovesen BL, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP (1993) Effect of dietary counselling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective randomised study. J Clin Oncol 11:2043–2049
    PubMed Google Scholar
  43. Ovesen L, Hannibal J, Mortensen EL (1993) The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 19:159–167
    PubMed Google Scholar
  44. Ozols RF, Young RC (1991) Ovarian cancer: where to next? Semin Oncol 18:307–310
    PubMed Google Scholar
  45. Ozols RF, Young RC (1991) Chemotherapy of ovarian cancer. Semin Oncol 18:222–232
    PubMed Google Scholar
  46. Payne SA (1992) A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med 35:1505–1509
    PubMed Google Scholar
  47. Petru E, Sevin BU, Averette HE, Koechli OR, Hilsenbeck S (1991) Long-term survival in stage II and IV ovarian cancer. Arch Gynaecol Obstet 249:87–93
    Google Scholar
  48. Portenoy RK, Thaler HT, Kornblith AB, et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30:1326–1336
    Google Scholar
  49. Portenoy RK, Thaler HT, Kornblith AB, et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189
    PubMed Google Scholar
  50. Portenoy RK, Kornblith AB, Wong G, Vlamis V, Lepore JM, Loseth DB (1994) Pain in ovarian cancer patients: prevalence, characteristics, and associated symptoms. Cancer 74:907–915
    PubMed Google Scholar
  51. Roberts CS, Rossetti K, Cone D, Cavanagh D (1992) Psychosocial impact of gynecologic cancer: a descriptive study. J Psychosoc Oncol 10(1):99–109
    Google Scholar
  52. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients-the Functional Living Index-Cancer: development and validation. J Clin Oncol 2:472–483
    PubMed Google Scholar
  53. Spitzer WO, Dobson AJ, Hall J, et al (1981) Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. J Chronic Dis 34:585–597
    PubMed Google Scholar
  54. Tchekmedyian NS, Call DF (eds) (1990) Quality of life in current oncology practice and research. Oncology 4 (special issue)
  55. Walczak JR, Brady M (1991) Comparison of quality of life (QOL) in ovarian cancer patients participating in a national cooperative group phase III randomised trial (abstract). Proc ASCO 10: A1185
    Google Scholar
  56. Warde P, Strugeon JF, Fine S, Hogg SA, Boyd NF (1984) Quality of life assessment in patients with carcinoma of the ovary (abstract). Proc ASCO 3: C-266
  57. Watson M, Law M, Maguire GP, et al (1992) Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised). Psycho-Oncology 1:35–44
    Google Scholar
  58. Willemse PB, Lith J van, Mulder NH, et al (1990) Risk and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis. Eur J Cancer 26:345–352
    PubMed Google Scholar
  59. Willemse PB, Assendelft PH van, Fontein DL, Kloppenburg M, Boonstra H, Vries EG de (1991) Carboplatin in the treatment of ovarian carcinom; as effective and less toxic in comparison with cisplatin (in Dutch). Ned Tijdschr Geneeskd 135:1588–1592
    PubMed Google Scholar
  60. Williams C (1992) Ovarian and cervical cancer. Br Med J 304:1501–1504
    Google Scholar

Download references